Chime Financial (CHYM) News Today

Chime Financial, Inc. (NASDAQ:CHYM) is benefiting from a more bullish analyst outlook, although substantial insider selling is creating a countervailing concern. Shares are trading near their 52-week high after a strong recent rally, with the stock well above its 50-day and 200-day moving averages.

• Positive Sentiment: Wolfe Research raised its price target on Chime Financial (CHYM) from $32 to $38 and reiterated an “outperform” rating, implying additional upside from recent trading levels. Benzinga analyst update
• Positive Sentiment: Wells Fargo increased its target from $33 to $39 and maintained an “overweight” rating. The move reinforces the view that Chime’s growth and improving profitability could support a higher valuation. Benzinga analyst update
• Positive Sentiment: The latest quarterly results provide fundamental support: Chime reported $0.07 in earnings per share versus a projected loss of $0.01, while revenue rose 26.8% year over year to approximately $669.8 million.

• Neutral Sentiment: The reported short-interest data shows zero shares sold short both before and after the update, making the stated percentage increase and zero-day days-to-cover figure economically meaningless. It offers no useful evidence of short covering or rising bearish positioning.

• Negative Sentiment: Major shareholder Global Advisors Ltd. DST has sold millions of CHYM shares in a series of August transactions, including 383,031 shares on August 20 and 473,694 shares on August 21. The reported sales reduced its position by roughly half and may pressure the stock or raise concerns about profit-taking by an early investor. Global Advisors share sale
• Negative Sentiment: A Chime executive also sold shares, reportedly primarily to cover tax liabilities. Because the transaction appears tax-related rather than a clear discretionary exit, its bearish significance is more limited. Executive share sale

Overall, the immediate bullish catalyst for CHYM is the wave of higher analyst targets, supported by strong revenue growth and a recent earnings beat. Heavy shareholder selling is the main risk, particularly with the stock already trading at an elevated valuation and still reporting a negative net margin.